OCTOBER 26-27 2020 | BOSTON, MA

Connecting Biopharma’s
science and technology

Why attendees say they wouldn't miss the Summit...

Engage in honest, collaborative conversation

  • Conversations that take place are high-value, and attendees always leave with new ideas and contacts
  • Our uniquely accomplished group of speakers stay for the duration of the event to share their experiences using AI tools & technologies and answer questions
  • The DEEP DIVE sessions facilitate honest, in-depth discusssions on specific use cases which energize collaboration

Over 60 speakers ready to share their expertise

  • From big pharma, to AI platform companies, speakers are ready to share their first-hand experience, challenges, opportunites in implementing AI
  • Hear only from companies actually applying and using AI tools and technologies through structured use case formats
  • Hear from innovative start-ups, including a variety of AI technology platform companies and potential new partners

Deep coverage of AI applications across the biopharma pipeline, with tracks focused on...

  • Research & discovery
  • Clinical development
  • Data management and RWE
  • Genomics
  • Strategy & Leadership

Currently, drug discovery is a blind search through chemical libraries, which is not that efficient. The AI Applications Summit is an important gathering of thought leaders to discuss better options, such as generative AI models, which can potentially speed up the drug discovery process by proposing a limited amount of high promising molecules instead of thousands with unknown activities and possibly increase the drug space (finding new drug, a new mechanism of action, new chemistry).

Polina Mamoshina, Research Scientist,Pharma AI a division of Insilico Medicine

Past and current speakers

Heather A. Arnett, Ph.D

Vice President, Research

Robert Abel, Ph.D

Senior Vice President, Sciences

Martin Akerman

Co-founder and CTO

Ron Alfa, MD, Ph.D

Senior Vice President, Translational Discovery

Mohammed Ali

Global Head Digital Trials- Global Clinical Operations

Brandon Allgood

CTO and Co-Founder

Alex Aronov, Ph.D, MBA

Senior Director, Data Strategy & Solutions

Aaron Aude, M.S., M.B.

National Director, Enterprise Collaboration

Centric Consulting

Jörg Bentzien

Research Fellow, Discovery

Christopher Boone, Ph.D FACHE

Vice President, Global Medical Epidemiology & Big Data Analysis Lead

Ed Bowen

Vice President, AI & Machine Learning, Medicinal Science and Technology (MST)

Catherine Calarco

Senior Director, Industry Strategy and Marketing for Life Sciences

Janice Chang

Executive Vice President

Krishna Cheriath

Chief Data Officer

George Church, Ph.D

Professor of Genetics, Blavatnik Institute, Harvard Medical School; Director of HMS NHGRI-Center of Excellence in Genomic Science; Director of the Personal Genome Project

Harvard Medical School

Dr. Mark F. Ciaccio

Senior A.I. Data Scientist

Tom Davenport

Distinguished Professor

Vitaly Doban

Executive Director, Head of RWE Advanced and Applied Analytics

Dr. Bhaskar Dutta

Head of Technology and Analytics: Oncology Regulatory Science & Strategy

M. Khair ElZarrad, Ph.D, MPH

Deputy Director, Office of Medical Policy

Kyle Martin Flickinger

Vice President Bio Pharmaceutical Solution Strategy

Michael G. Frank

Director, World Wide R&D Strategy

Harry Glorikian

General Partner

Vipin Gopal, Ph.D

Chief Data and Analytics Officer

Rishi R. Gupta, Ph.D

Principal Research Scientist, Data Science & Informatics

Kate Hilyard, Ph.D

Chief Operating Officer

Janak Joshi

Senior Vice President, Chief of Technology and Head of Strategy

Dr. Milind Kamkolkar

Chief Data Officer

Cellarity

Gabriela Lavezzari

Head of Global R&D Policy

Joseph Lehar

VP of Data Science, Oncology

Bolan Linghu, Ph.D

Associate Director, Oncology Bioinformatics

Charles Makin, BSPharm, MS, MBA, MM

Global Head, Real World Evidence Strategy

Brian S. Martin

Head of AI R&D Information Research

Dave Meyers

National Director US Life Sciences Industry

Matthew A. Michela

President and CEO

Ijah Mondesire-Crump, MD

Director of Clinical Research

Spyro Mousses, Ph.D

Chief Executive Officer

Systems Oncology

Nitin Naik

VP, Global Life Sciences

Niven R. Narain, Ph.D

Co-Founder, President & CEO

Jennifer K. Pai, ScD

Director, Data Sciences, Strategy & Platforms

Ulo Palm, MD, Ph.D

Senior Vice President, Head of Digital Sciences

Dr. Gunaretnam (Guna) Rajagopal

VP Global Head – Computational Sciences, Discovery Sciences

Meghan Raman

Head, R&D Data Lake and Analytics

John Reynders

Vice President, Data Science, Genomics, and Bioinformatics

Birgit Schoeberl, Ph.D

Global Head of Modeling and Simulation, PK Sciences

Lixia Wang

Vice President, Biostatistics and Data Management

David Wild, Ph.D

Founder & President

4 packed content tracks

RESEARCH & DISCOVERY

Enhanced targeting, process improvement, using predictive analytics to rank and prioritize assets in the move toward more personalized medicines, collaboration models as a vital component to a fundamental commitment to R&D.

CLINICAL DEVELOPMENT

ADME Tox, Pharmacovigilance, Patient Recruitment, Adherence and Retention in Clinical Trials, Digital Therapeutics and Virtual and Hybrid Trials.

GENOMICS

How organizations are using genomic data in specific therapeutic areas; What insights are being drawn from genomic data sets; What information is being parsed and what's useful in enabling outcomes.

STRATEGY & LEADERSHIP

For scientific and technology leaders - where the industry is headed, what is needed to move faster, how shifts in business models, organizational structure, automation, and talent management are important in driving the industry forward.

Sponsors

Never miss an announcement